SEROMYCIN- cycloserine capsule Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

seromycin- cycloserine capsule

parsolex gmp center, inc. - cycloserine (unii: 95ik5ki84z) (cycloserine - unii:95ik5ki84z) - indications and usage seromycin ® is indicated in the treatment of active pulmonary and extrapulmonary tuberculosis (including renal disease) when the causative organisms are susceptible to this drug and when treatment with the primary medications (streptomycin, isoniazid, rifampin, and ethambutol) has proved inadequate. like all antituberculosis drugs, seromycin ® should be administered in conjunction with other effective chemotherapy and not as the sole therapeutic agent. seromycin ® may be effective in the treatment of acute urinary tract infections caused by susceptible strains of gram- positive and gram-negative bacteria. use of seromycin ® in these infections should be considered only when more conventional therapy has failed and when the organism has been demonstrated to be susceptible to the drug. contraindications administration is contraindicated in patients with any of the following: • hypersensitivity to seromycin

CYCLOSERINE Зимбабве - Енглески - Medicines Control Authority

cycloserine

macleods pharmaceuticals ltd - cycloserine - capsule; oral - 250mg

CYCLOSERINE 250 MG 250 MG ORAL SOLID ORDINARY CAPSULES Уганда - Енглески - National Drug Authority

cycloserine 250 mg 250 mg oral solid ordinary capsules

mylan laboratories limited - cycloserine - oral solid ordinary capsules - 250 mg

CYCLOSERINE Зимбабве - Енглески - Medicines Control Authority

cycloserine

mylan laboratories limited [otl] - cycloserine - capsule - 250mg